NO993085L - 3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon - Google Patents
3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjonInfo
- Publication number
- NO993085L NO993085L NO993085A NO993085A NO993085L NO 993085 L NO993085 L NO 993085L NO 993085 A NO993085 A NO 993085A NO 993085 A NO993085 A NO 993085A NO 993085 L NO993085 L NO 993085L
- Authority
- NO
- Norway
- Prior art keywords
- aryl
- lower alkyl
- acyl
- hydrogen
- piperidinyl
- Prior art date
Links
- -1 1-substituted-4-piperidinyl Chemical group 0.000 title abstract 2
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical class C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 title 1
- 239000002858 neurotransmitter agent Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 125000002252 acyl group Chemical group 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 229940005513 antidepressants Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000010249 dopaminergic function Effects 0.000 abstract 1
- 230000003291 dopaminomimetic effect Effects 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77486696A | 1996-12-23 | 1996-12-23 | |
| PCT/US1997/021178 WO1998028295A1 (en) | 1996-12-23 | 1997-11-13 | 3-aryl-2-(1-substituted-4-piperidinyl)-1(1-di)oxo-3h-benzo[d]-isothiazole derivatives, their preparation and their use as modulators of neurotransmitter function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993085D0 NO993085D0 (no) | 1999-06-22 |
| NO993085L true NO993085L (no) | 1999-08-20 |
Family
ID=25102528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993085A NO993085L (no) | 1996-12-23 | 1999-06-22 | 3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0956287B1 (de) |
| JP (1) | JP3282827B2 (de) |
| KR (1) | KR20000062283A (de) |
| AR (1) | AR009440A1 (de) |
| AT (1) | ATE247111T1 (de) |
| AU (1) | AU716689B2 (de) |
| BR (1) | BR9714432A (de) |
| CA (1) | CA2273181C (de) |
| DE (1) | DE69724148T2 (de) |
| DK (1) | DK0956287T3 (de) |
| ES (1) | ES2200205T3 (de) |
| HU (1) | HUP9904071A3 (de) |
| IL (1) | IL130605A0 (de) |
| NO (1) | NO993085L (de) |
| PT (1) | PT956287E (de) |
| WO (1) | WO1998028295A1 (de) |
| ZA (1) | ZA9711337B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1393351B1 (it) * | 2009-03-16 | 2012-04-20 | Eos Ethical Oncology Science Spa In Forma Abbreviata Eos Spa | Procedimento per la preparazione della 6-(7-((1-amminociclopropil)metossi)-6-metossichinolin-4-ilossi)-n-metil-1-naftammide e suoi intermedi di sintesi |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2509797C2 (de) * | 1975-03-06 | 1985-07-18 | Dr. Karl Thomae Gmbh, 7950 Biberach | Phthalimidine, deren physiologisch verträgliche Säureadditionssalze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| AT345806B (de) * | 1975-03-06 | 1978-10-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer substituierter arylalkylamine und deren salze |
| EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
| FR2662696A2 (fr) * | 1989-12-13 | 1991-12-06 | Rhone Poulenc Sante | Antagonistes de la serotonine, leur preparation et medicaments les contenant. |
| US5567718A (en) * | 1994-08-11 | 1996-10-22 | Hoechst Marion Roussel Inc. | 2,3-dihydro-1h-isoindole derivatives and their use as serotonin reuptake inhibitors |
-
1997
- 1997-11-13 PT PT97950636T patent/PT956287E/pt unknown
- 1997-11-13 BR BR9714432-0A patent/BR9714432A/pt not_active Application Discontinuation
- 1997-11-13 ES ES97950636T patent/ES2200205T3/es not_active Expired - Lifetime
- 1997-11-13 HU HU9904071A patent/HUP9904071A3/hu unknown
- 1997-11-13 DE DE69724148T patent/DE69724148T2/de not_active Expired - Fee Related
- 1997-11-13 KR KR1019997005678A patent/KR20000062283A/ko not_active Ceased
- 1997-11-13 IL IL13060597A patent/IL130605A0/xx unknown
- 1997-11-13 WO PCT/US1997/021178 patent/WO1998028295A1/en not_active Ceased
- 1997-11-13 CA CA002273181A patent/CA2273181C/en not_active Expired - Fee Related
- 1997-11-13 EP EP97950636A patent/EP0956287B1/de not_active Expired - Lifetime
- 1997-11-13 JP JP52874198A patent/JP3282827B2/ja not_active Expired - Fee Related
- 1997-11-13 AU AU53588/98A patent/AU716689B2/en not_active Ceased
- 1997-11-13 DK DK97950636T patent/DK0956287T3/da active
- 1997-11-13 AT AT97950636T patent/ATE247111T1/de not_active IP Right Cessation
- 1997-12-17 ZA ZA9711337A patent/ZA9711337B/xx unknown
- 1997-12-19 AR ARP970106005A patent/AR009440A1/es unknown
-
1999
- 1999-06-22 NO NO993085A patent/NO993085L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69724148D1 (de) | 2003-09-18 |
| DE69724148T2 (de) | 2004-06-09 |
| HUP9904071A2 (hu) | 2000-05-28 |
| BR9714432A (pt) | 2000-05-02 |
| IL130605A0 (en) | 2000-06-01 |
| DK0956287T3 (da) | 2003-11-24 |
| CA2273181C (en) | 2004-01-20 |
| CA2273181A1 (en) | 1998-07-02 |
| ES2200205T3 (es) | 2004-03-01 |
| AU5358898A (en) | 1998-07-17 |
| PT956287E (pt) | 2003-11-28 |
| JP3282827B2 (ja) | 2002-05-20 |
| WO1998028295A1 (en) | 1998-07-02 |
| EP0956287A1 (de) | 1999-11-17 |
| KR20000062283A (ko) | 2000-10-25 |
| ATE247111T1 (de) | 2003-08-15 |
| ZA9711337B (en) | 1998-06-23 |
| EP0956287B1 (de) | 2003-08-13 |
| HUP9904071A3 (en) | 2000-07-28 |
| JP2001520641A (ja) | 2001-10-30 |
| NO993085D0 (no) | 1999-06-22 |
| AR009440A1 (es) | 2000-04-12 |
| AU716689B2 (en) | 2000-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2776510B1 (fr) | Derives de polyamino-acides et leur utilisation dans des compositions de traitement des fibres keratiniques | |
| MA29649B1 (fr) | Nouveaux derives de 2,4- dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk | |
| PT1437123E (pt) | Composição de tintura das fibras queratínicas e processo de tintura utilizando esta composição | |
| DE69503803D1 (de) | 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament | |
| KR930701434A (ko) | 옥사졸리딘 디온 유도체 | |
| HUT77225A (hu) | Kondenzált izoxazol-oxi- és -tio-alkil-amin-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| CH622699A5 (de) | ||
| CA2370805A1 (en) | Ureas as cell adhesion modulators | |
| HUP0303281A2 (hu) | Benzodiazepinszármazékok, mint GABA A receptor modulátorok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| DK0959906T3 (da) | Delta 1,6 bicyclo[4,4,0] funktionelle farver til kontrastforøgelse ved optisk afbildning | |
| DE69103481D1 (de) | Färbemittel, enthaltend 5-6-Dihydroxyindoline und Färbungsverfahren für keratinische Fasern. | |
| BRPI0407695A (pt) | compostos, processo para a preparação de um composto, composições farmacêuticas que compreendem o composto, utilização dos compostos e processo de tratamento para diabetes do tipo 2 | |
| CA2102095A1 (fr) | Composition cosmetique contenant des pigments melaniques en association avec certains tocopherols, et procede de protection de la peau, des cheveux, des muqueuses et des compositions cosmetiques | |
| HUP0002853A2 (hu) | 6,7-Helyzetben aszimmetrikusan diszubsztituált kinoxalinkarbonsav-származékok, és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| AR000080A1 (es) | Nuevos derivados de triorganosilano de benzotriazoles, su uso como filtros solares, composiciones cosmeticas fotoprotectoras que los contienen y procedimiento para la proteccion de la piel y/o los cabellos contra la radiacion uv mediante los mismos. | |
| TR200103349T2 (tr) | Purin türevleri, hazırlama usulü ve bunları içeren ispençiyari bileşimleri. | |
| DK0648741T3 (da) | 1,2,3,4-tetrahydronaphthalen-, chroman- og thiochroman-derivater som antithrombotiske midler | |
| NO20012965L (no) | Sulfonyloksazolaminer som terapeutisk aktive forbindelser | |
| MY113427A (en) | Anti-neurodegeneratively active 10-aminoaliphatyl- dibenz [b,f] oxepines | |
| ATE289190T1 (de) | Verwendung von 1-substituierten isatinen zum färben von keratinhaltigen fasern | |
| NO975094L (no) | Vinylpyrrolidoncefalosporinderivater | |
| ES2191341T3 (es) | Derivados de la 2-fenoxianilina. | |
| NO993085L (no) | 3-aryl-2-(1-substituerte-4-piperidinyl)-1(1-di)okso-3H-benzo[d]-isothiazolderivater, deres fremstilling og deres anvendelse som modulatorer av neurotransmitter funksjon | |
| WO2001049686A1 (fr) | Derives de s-triazine et leur utilisation comme filtres uv | |
| BR0007918A (pt) | Processo para preparar oxazolidinonas cìclicas contendo flúor e enxofre |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |